Causal effects between atrial fibrillation and heart failure: evidence from a bidirectional Mendelian randomization study
Related Experiment Video
Updated: Jul 19, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Zhuxin Zhang1, Le Li1, Zhao Hu1
1Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Atrial fibrillation (AF) and heart failure (HF) have a reciprocal causal relationship. Genetic predisposition to AF increases HF risk, and genetically determined HF elevates AF risk, supporting bidirectional causality.
Area of Science:
- Cardiovascular Genetics
- Epidemiology
- Translational Medicine
Background:
- Observational studies indicate a strong association between atrial fibrillation (AF) and heart failure (HF).
- The causal relationship between AF and HF remains uncertain, necessitating further investigation.
- Genetic factors may play a significant role in the interplay between AF and HF.
Purpose of the Study:
- To investigate the causal effect of atrial fibrillation on heart failure.
- To examine the causal effect of heart failure on atrial fibrillation.
- To establish a bidirectional causal relationship between AF and HF using genetic data.
Main Methods:
- Bidirectional Mendelian randomization (MR) analysis was employed.
- Genetic instrumental variables were derived from large-scale genome-wide association studies for AF (n=1,030,836) and HF (n=1,665,481).
- Inverse-variance weighted (IVW) was the primary estimation method, with MR-PRESSO, MR-Egger, and weighted median analyses used for sensitivity and pleiotropy assessment.
Main Results:
- A genetically elevated predisposition to atrial fibrillation was associated with an increased risk of heart failure (OR=1.18, 95% CI: 1.14-1.22).
- Genetically determined heart failure was associated with an increased risk of atrial fibrillation (OR=1.44, 95% CI: 1.23-1.68).
- MR sensitivity analyses confirmed the robustness of these findings, indicating a consistent bidirectional causal link.
Conclusions:
- This bidirectional Mendelian randomization study supports a reciprocal causal relationship between AF and HF.
- The shared genetic architecture of AF and HF offers potential therapeutic targets for disease prevention and management.
- Further research into molecular mechanisms and personalized genetic profiling is warranted for effective treatment strategies.
Background:
Observational studies have suggested a close association between atrial fibrillation (AF) and heart failure (HF), yet the causal effect remains uncertain. In this study, we employed a bidirectional Mendelian randomization analysis to investigate the causal effect of one disease on the other.
Methods:
Genetic instrumental variables were obtained from large-scale summary-level genome-wide association studies of AF (n = 1,030,836) and HF(n = 1,665,481), respectively. Two-sample Mendelian randomization was conducted to establish causal inferences. Inverse-variance weighted (IVW) was the primary estimate, while additional analyses including MR Pleiotropy RESidual Sum and Outlier (MR-PRESSO), MR-Egger, and Weighted median were performed to validate robustness and identify pleiotropy.
Results:
After accounting for confounding variables, MR analysis suggested a potential causal relationship between AF and HF. An augmented genetic predisposition to atrial fibrillation was associated with an elevated risk of heart failure (odds ratio (OR) = 1.18, 95% confidence interval (CI):1.14-1.22). Likewise, genetically determined heart failure also increased the risk of heart failure (OR = 1.44, 95%CI:1.23-1.68). The robustness of the findings was corroborated through MR sensitivity analyses, and the causal estimates remained consistent when the instrument P-value threshold was tightened.
Conclusions:
Our bidirectional Mendelian randomization study supports a reciprocal causal relationship between AF and HF. The shared genetic profile of these conditions may provide crucial insights into potential therapeutic targets for the prevention and progression of both disorders. These findings underscore the necessity for further investigation into the underlying molecular mechanisms linking AF and HF, as well as the potential for personalized treatment strategies grounded in genetic profiling.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure Drugs: β-Blockers
Heart Failure V: Medical Management

